# Open Access Transformation in Switzerland & Germany > ./scidecode

“Christian Gutknecht published an exciting posting on the Swiss EUR 57 million Elsevier deal in which he outlines the transformative Open Access agreement between Elsevier and swissuniversities. Since Germany has been trying for years to reach such a contract with Elsevier, it is worth comparing it with the two transformative contracts with Wiley and Springer Nature in Germany, which were reached and coordinated by Project DEAL. Both German agreements were discussed here before just as other transformative Open Access agreements. For those in a hurry: At the end of the posting there is a synopsis of the costs and Open Access components of the Open Access Transformation in Switzerland & Germany. At the very beginning I would like to thank Christian Gutknecht very much for sharing and discussing information that went into this posting….”

# Open access publizieren dank DEAL-Vereinbarung | SpringerLink

Since the beginning of this year it has been even more worthwhile to publish your “originals”, “overviews”, “case reports” and “picture and case” articles in Der Ophthalmologe . In addition to the wide range of subscribers to the journal, which covers over 90% of all ophthalmologists working in Germany, you now also have the opportunity to publish your freely submitted work via the DEAL open access project.”

# Open access publizieren dank DEAL-Vereinbarung | SpringerLink

Since the beginning of this year it has been even more worthwhile to publish your “originals”, “overviews”, “case reports” and “picture and case” articles in Der Ophthalmologe . In addition to the wide range of subscribers to the journal, which covers over 90% of all ophthalmologists working in Germany, you now also have the opportunity to publish your freely submitted work via the DEAL open access project.”

# AI in Medicine, Covid-19 and Springer Nature’s Open Access Agreement

“Just at the right time, we are happy to announce Springer Nature’s Open Access Agreement (read more in the News section of the KI Journal): if you are a corresponding author affiliated with a German university or research institution, you are entitled to publish open access in our KI Journal with fees covered by the German DEAL agreement. This means everyone in the German AI research community can, from now on, publish open access in our KI Journal for free, with Scopus Index! …”

# A DEAL for open access: The negotiations between the German DEAL project and publishers have global implications for academic publishing beyond just Germany: EMBO reports: Vol 19, No 6

“Impatience over the slow progress has been particularly strong in Germany, where universities and funding institutions have been at the vanguard of the OA movement. It eventually led to the DEAL project (https://www.projekt-deal.de/about-deal/) set up in 2014 by the Alliance of Science Organisations in Germany and led by the country’s Rectors’ Conference (HRK). A key objective was to establish national licensing agreements for the entire electronic portfolio from the large academic publishers. In addition, DEAL aims to further advance OA; one of its goals is to make all publications from corresponding authors of eligible institutions in Germany open access immediately upon publication, that being the publish part of its strategy. By the same token, DEAL institutions should have full access to the complete e?journal portfolio of the publisher—the read part of DEAL. Equally important, DEAL wants to establish fair article?processing fees to cover publication costs.

DEAL began negotiating with Elsevier late in 2016, followed by Springer Nature and Wiley in 2017. Negotiations proceeded relatively smoothly with Springer Nature and Wiley, according to DEAL. Both publishers accepted that the journals market was undergoing radical transformation and agreed to continue existing agreements on an interim basis with prices frozen in order to allow negotiations to conclude. A new DEAL licence is now expected to start during 2018.

However, agreement has not been reached yet with Elsevier, the biggest of the three, whose offers have so far failed to match the project’s goals, according to DEAL. For example, Elsevier would only offer green open access—that is, self?archiving in an open repository—in accordance with its own rules, which would mean that scientists would not have open access to the final, published version of their papers. Above all, Elsevier wants to keep the publish and read components separate, whereas a non?negotiable red line for DEAL was to integrate them in a single model, because they are entwined and determine overall access rights and costs….

There is an important aspect of DEAL not explicitly stated, which is that, although focused on Germany, it is global in ambition and scope….”

# Open Access publizieren dank DEAL-Vereinbarung | SpringerLink

From Google’s English:  “From the beginning of this year it will be even more worthwhile to publish your original works, overviews and casuistics in “The Pathologist”. In addition to the wide reach in the magazine’s subscriber base, which reaches a large number of pathologists in Germany, you have also been able to publish your freely submitted works on the DEAL Open Access project since the beginning of the year . In the following we would like to inform you about its general conditions.”

# Project DEAL — Germany is leading the way in the transition to open access publishing – Mills – – Journal of Applied Clinical Medical Physics – Wiley Online Library

“Pioneers in the open access movement are gratified, and more than a little relieved, to see the world moving in our direction. Over the past several years, several consortiums of national research institutions and libraries, notably Sweden, the Netherlands, Norway, Hungary, and Germany, have initiated negotiations with the leading electronic journal publishing houses including Wiley, Springer, and Elsevier. This editorial focuses on one of the more successful initiatives, Project DEAL (Projekt DEAL), in Germany. The goal of this endeavor is to rewrite the nationwide agreements for licensing content in electronic journals. Under the terms of these negotiations, scientists in Germany would get immediate and full online access to most of the electronic content of a publisher’s journals. In exchange, the publication costs for the German authors would be subsidized, and all of their articles would be published immediately open access. This “publish and read” model makes all articles available to anyone with web access, and additionally, authors have access to all electronic journals of the publisher, including archives….”

# John Wiley & Sons: It’s Time To Pound The Table – John Wiley & Sons, Inc. (NYSE:JW.A) | Seeking Alpha

How Wiley and Sons is Positioned Against Open Access

John Wiley & Sons is a mainly digital business. According to their 2019 annual report (Pages 25-27) the plurality of their earnings come from their research division where online academic journal subscriptions are their bread and butter. In fact, their reliance on online journal subscriptions is shown by the observation that it contributes more than half of their profits for their research segment. This sector also has continuously seen a decrease over the past 2 years. This decline is likely related to the growth of the open access publishing movement going on in academia. John Wiley and Sons understands this movement as well and has taken steps to accommodate. Between 2018 and 2019, they’ve increased their open access journal revenue by 30%. Where does this money come from though? It just so happens that authors have to pay a fee to publish their papers in Wiley and Sons online journals. These fees range anywhere between $500-$2000 fee per publication. Another avenue of revenue from their open access journals is that they contain advertisements.

Regarding Open Access, Wiley currently offers two models of Open Access that is at the author’s choice. A fully open access journal or a subscription journal offering called OnlineOpen is called Gold. The other option, Green, is free to the author, but allows for a 12 to 24-month embargo period. Wiley cites in its 2019 10-K that the hybrid open access is only available to authors that are publishing in the majority of the company’s academic journals are able to make their articles available through Wiley’s OnlineOpen. This is a network effect in play, if you want to publish in a particularly respected journal, you must access it via the Wiley tollroad. Not only that, the as stated below by Wiley and Sons, the open access journals cover a wide array of disciplines as per their 2019 10-K ….”

# „Open access“ publizieren dank DEAL-Vereinbarung | SpringerLink

From Google’s English:  “Since the beginning of this year it has been even more worthwhile to publish your original work in the ENT . In addition to the wide reach in the magazine’s subscriber base, which covers the entire team of ear, nose and throat medicine, head and neck surgery, you have also been able to submit your freely submitted work on the DEAL “open access” project since the beginning of the year publish. Read on to find out more about the framework: …”

# „Open access“ publizieren dank DEAL-Vereinbarung | SpringerLink

From Google’s English:  “Since the beginning of this year it has been even more worthwhile to publish your original work in the ENT . In addition to the wide reach in the magazine’s subscriber base, which covers the entire team of ear, nose and throat medicine, head and neck surgery, you have also been able to submit your freely submitted work on the DEAL “open access” project since the beginning of the year publish. Read on to find out more about the framework: …”